Multiple Myeloma With Isolated Plasmacytoma in Temporal Bone

2013 ◽  
Vol 34 (7) ◽  
pp. e107-e108 ◽  
Author(s):  
Hyung Jin Jun ◽  
June Choi ◽  
Kyoung Min Kim ◽  
Sung Won Chae
2004 ◽  
Vol 15 (2) ◽  
pp. 299-302
Author(s):  
Seung Choul Choi ◽  
Jae Keun Lee ◽  
Yong Joo Yoon

2006 ◽  
Vol 27 (4) ◽  
pp. 580-581 ◽  
Author(s):  
Boris G. Naraev ◽  
Fred H. Linthicum

2019 ◽  
Vol 5 (4) ◽  
pp. 111-113
Author(s):  
N Albakheet ◽  
E Essa ◽  
YA Shawi ◽  
K Almuhanna

2008 ◽  
Vol 19 (2) ◽  
pp. 200-204
Author(s):  
Il Ho Shin ◽  
Jae Yong Byun ◽  
Mun Suh Park

1994 ◽  
Vol 104 (6) ◽  
pp. 675???680 ◽  
Author(s):  
Wuyi Li ◽  
Patricia A. Schachern ◽  
Tetsuo Morizono ◽  
Michael M. Paparella

2019 ◽  
Vol 5 (4) ◽  
pp. 111-113
Author(s):  
Albakheet Nouf ◽  
Ahmed Elaf Essa ◽  
Al-Shawi Yazeed ◽  
Almuhanna Khabti

1998 ◽  
Vol 112 (5) ◽  
pp. 469-471 ◽  
Author(s):  
D. Quinodoz ◽  
P. Dulguerov ◽  
A.-M. Kurt ◽  
D. Ruefenacht ◽  
R. Abele ◽  
...  

AbstractThe manifestations of multiple myeloma are protean and related to bony osteolytic lesions, and to medullar and renal insufficiency. We report a patient who presented with otalgia as the inaugural symptom of multiple myeloma. Local irradiation combined with systemic chemotherapy led to the disappearance of the temporal bone mass and the accompanying symptoms. To date, 24 months after the diagnosis, the patient is still in remission.The literature on otological involvement in multiple myeloma is reviewed. Symptoms are non-specific and include hearing loss, tinnitus, dizziness, facial paralysis, and otalgia. The diagnosis of multiple myeloma should be considered in the presence of a temporal bone mass.


Author(s):  
JG Aishwarya ◽  
Satish Nair ◽  
Parameswaran Anoop ◽  
Swarna Shivakumar ◽  
ArunaR Patil ◽  
...  

2006 ◽  
Vol 27 (4) ◽  
pp. 580-581
Author(s):  
Boris G. Naraev ◽  
Fred H. Linthicum

2013 ◽  
Vol 127 (S2) ◽  
pp. S51-S53 ◽  
Author(s):  
N Wickham ◽  
A Crawford ◽  
A S Carney ◽  
A N Goss

AbstractBackground:Osteonecrosis is a benign condition characterised by necrotic exposed bone, and is associated with bisphosphonate use. Osteonecrosis of the external auditory canal is rare, with only a few reported cases.Method:Two case reports of temporal bone osteonecrosis are presented.Results:A 64-year-old man with a history of immunoglobulin G kappa multiple myeloma developed a right external auditory canal ulcer 6 years after commencement on clodronate. A 72-year-old woman taking alendronate for osteoporosis, initially diagnosed and treated for right-sided otitis externa, was found to have underlying exposed bone in the right external auditory canal, with a computed tomography scan confirming destruction of the temporal bone.Conclusion:With increasing use of both oral and intravenous bisphosphonates in the community for benign conditions such as osteoporosis and for malignant conditions such as breast cancer and multiple myeloma, the diagnosis of bisphosphonate-associated osteonecrosis should always be considered in patients with a temporal bone lesion, and a relevant drug history taken.


Sign in / Sign up

Export Citation Format

Share Document